1. During the week of Sept. 22 it was noted that Biogen could be sold short upon the weekly close which occurred at $333.54. The forecast was for a quick decline to at/near $320/$19.
2. Subsequently on Thurs., Oct. 2 Biogen declined to $317.53, completing the $320/$19 downside target and completing the trade. Will message any further entry or indication in Biogen as the market confirms.